Haemonetics Corporation (HAE)

Haemonetics Market Cap

Haemonetics has a market cap or net worth of $3.17 billion as of March 31, 2025. Its market cap has decreased by -18.31% in one year.

• Market Cap: 3.17B
• Enterprise Value: 4.15B
• 1-Year Change: -18.31%
• Ranking: #1560
• Category: Mid-Cap
• Stock Price: $63.04

Market Cap Chart

Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $3.17B, an increase of 423.47%. That is a compound annual growth rate of 6.49%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	3.17B	-19.05%
Dec 31, 2024	3.92B	-9.62%
Dec 29, 2023	4.34B	9.01%
Dec 30, 2022	3.98B	46.84%
Dec 31, 2021	2.71B	-55.05%
Dec 31, 2020	6.03B	3.54%
Dec 31, 2019	5.82B	12.62%
Dec 31, 2018	5.17B	68.56%
Dec 29, 2017	3.07B	47.73%
Dec 30, 2016	2.08B	26.98%
Dec 31, 2015	1.64B	-14.87%
Dec 31, 2014	1.92B	-11.51%
Dec 31, 2013	2.17B	3.06%
Dec 31, 2012	2.11B	37.73%
Dec 30, 2011	1.53B	-2.18%
Dec 31, 2010	1.56B	10.69%
Dec 31, 2009	1.41B	-1.15%
Dec 31, 2008	1.43B	-10.77%
Dec 31, 2007	1.60B	32.14%
Dec 29, 2006	1.21B	-6.31%
Dec 30, 2005	1.29B	40.58%
Dec 31, 2004	920.10M	59.08%
Dec 31, 2003	578.40M	10.51%
Dec 31, 2002	523.40M	-41.55%
Dec 31, 2001	895.40M	15.08%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	738.61B
UnitedHealth Group	472.03B
Johnson & Johnson	394.52B
AbbVie	363.15B
Novo Nordisk	305.46B
AstraZeneca	229.16B
Abbott Laboratories	226.88B
Merck & Co.	225.40B